Zomedica Announces First Quarter 2019 Financial Results
May 10, 2019 17:21 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today...
Zomedica Announces Private Placement of Preferred Shares
May 10, 2019 06:00 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Announces 2018 Annual Meeting Results
August 15, 2018 16:15 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Pharmaceuticals Corp. Announces Second Quarter 2018 Financial Results
August 09, 2018 16:01 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results
May 11, 2017 16:15 ET
|
Zomedica
ANN ARBOR, Mich., May 11, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported...
Zomedica Announces Adoption of Advance Notice Bylaw
April 28, 2017 16:15 ET
|
Zomedica
ANN ARBOR, Mich., April 28, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, announces...
Zomedica Raises C$4.35 Million in Second Tranche Closing of Equity Financing for Aggregate Proceeds of C$5.54 Million
April 10, 2017 06:55 ET
|
Zomedica
ANN ARBOR, Mich., April 10, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical company and health care solutions company, today announced the closing of...
Zomedica Retains Renmark Financial Communications to Enhance Investor Outreach and Extends Equity Offering
November 07, 2016 19:03 ET
|
Zomedica
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ANN ARBOR, Mich., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM)...
Zomedica Announces Continuation of Aggregate C$15.0 Million Equity Financing
October 06, 2016 18:00 ET
|
Zomedica
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESANN ARBOR, Mich., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a...
Zomedica Appoints Two Animal Health Veterans to Board of Directors
October 04, 2016 06:55 ET
|
Zomedica
ANN ARBOR, Mich., Oct. 04, 2016 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical company, today announced it has appointed Jane Eagleson and Tom...